title: Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients.
abstract: BACKGROUND
  Recurrence of nephrotic syndrome (NS) after renal transplantation for primary focal segmental glomerulosclerosis (FSGS) is a frequent and still unpredictable complication. However, risk factors for recurrence have not yet been clearly identified.
  
  
  METHODS
  Data from 33 patients who underwent 35 renal transplantations for FSGS in two French centres are reported.
  
  
  RESULTS
  Recurrent NS occurred in 12 transplant recipients (34%). A significantly higher number of patients in the group with recurrence (R group) compared with the group without recurrence (NR group) received cyclosporine for FSGS treatment before transplantation (83.3% vs 43.4%, P<0.02). Donors of R group recipients were significantly older than those of the non-NR group recipients (42.8 years vs 35 years, P<0.05). A higher number of patients from the R group required post-transplantation dialysis (33.3% vs 17.4%, P = 0.002). Surprisingly, acute rejection occurred more frequently in patients of the NR group compared with the R group, although the difference was not significant. Among the 12 patients with NS relapse, 9 were treated with plasmapheresis. Graft loss related to recurrence occurred in 6 cases. The 5-year graft survival was significantly lower in patients with recurrent NS compared with patients without recurrence (57% vs 82%, P<0.001).
  
  
  CONCLUSIONS
  This study confirms the benefit to identify in the future clinical or biological predictive risk factors for NS recurrence after renal transplantation. It also indicates that donor age is a reliable risk factor for recurrence in adult recipients and suggests for the first time a possible opposite relationship between recurrent FSGS and acute rejection.
authors.affiliation: Department of Nephrology and Transplantation, Hôpital Henri Mondor, Créteil, France.
authors.forename: Agathe
authors.initials: A
authors.lastname: Pardon
authors.forename: Vincent
authors.initials: V
authors.lastname: Audard
authors.forename: Sophie
authors.initials: S
authors.lastname: Caillard
authors.forename: Bruno
authors.initials: B
authors.lastname: Moulin
authors.forename: Dominique
authors.initials: D
authors.lastname: Desvaux
authors.forename: Bouteina
authors.initials: B
authors.lastname: Bentaarit
authors.forename: Philippe
authors.initials: P
authors.lastname: Remy
authors.forename: Dil
authors.initials: D
authors.lastname: Sahali
authors.forename: Françoise
authors.initials: F
authors.lastname: Roudot-Thoraval
authors.forename: Philippe
authors.initials: P
authors.lastname: Lang
authors.forename: Philippe
authors.initials: P
authors.lastname: Grimbert
mesh_terms: D000328:Adult; D005260:Female; D005919:Glomerular Filtration Rate; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology* / Q000601:surgery*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D012008:Recurrence; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome